According to GuruFocus Insider Data, the recent CFO sales were: Forest Laboratories Inc, U.S. Bancorp, PNC Financial Services Group Inc, and Gilead Sciences Inc.Â
Forest Laboratories Inc. (FRX, Financial): EVP Finance & Admin. and CFO Perier I Francis Jr sold 12,000 Shares
On Aug. 21, EVP Finance & Admin. and CFO Perier I Francis Jr sold 12,000 shares at an average price of $43. The price of the stock has increased by 51.05% since. Forest Laboratories Inc. has a market cap of $17.5 billion and its shares were traded at around $64.95. The company has a P/E ratio of 111.98 and P/S ratio of 5.39.
Forest Laboratories Inc. announced their 2013 third quarter results with revenues of $847.5 million and gross profit of $683.7 million; the net income was $69.98 million. The 2013 total revenue was $3.09 billion, a 32% decrease from the 2012 total revenue. The 2013 gross profit was $2.44 billion, a 31% decrease from the 2012 gross profit.
On Jan. 23, Director Howard Solomon sold 250,000 shares at an average price of $67.13. The price of the stock has decreased by 3.25% since. On Jan. 21, 2014, SVP-Sales Jerome Lynch sold 135,625 shares at an average price of $67.28. The price of the stock has decreased by 3.46% since. On Aug. 23, Director Lawrence S Olanoff sold 1,104 shares at an average price of $42.96. The price of the stock has increased by 51.19% since.
U.S. Bancorp (USB, Financial): Vice Chairman and CFO Andrew Cecere sold 259,355 Shares
On July 18, Vice Chairman and CFO Andrew Cecere sold 259,355 shares at an average price of $37.02. Â The price of the stock has increased by 0.65% since. U.S. Bancorp has a market cap of $73.31 billion and its shares were traded at around $40.14. The company has a P/E ratio of 13.50 and P/S ratio of 3.81. The dividend yield of U.S. Bancorp stocks is 2.20%; over the past 10 years, the company had an annual average earnings growth of 1.20% over the past 10 years.
U.S. Bancorp announced their 2013 third quarter results with revenues of $5.24 billion and net income of $1.47 billion. The company had a 2012 total revenue of $22.2 billion, a 3.8% increase from the 2011 total revenue. The 2012 net income was $5.6 billion, a 16% increase from the 2011 net income.
On Jan. 23, Vice Chairman P.W. Parker sold 316,696 shares at an average price of $40.56. The price of the stock has decreased by 1.04% since. On Jan. 23, Vice Chairman Pamela Joseph sold 292,604 shares at an average price of $40.63. The price of the stock has decreased by 1.21% since. On 11/12/2013, Director Victoria Buyniski Gluckman sold 158,500 shares at an average price of $37.88. The price of the stock has increased by 5.97% since.
PNC Financial Services Group Inc. (PNC, Financial): EVP and CFO Richard J. Johnson sold 30,000 Shares
On July 19, 2013, EVP and CFO Richard J. Johnson sold 30,000 shares at an average price of $76.58. The price of the stock has decreased by 0.27% since. PNC Financial Services Group Inc. has a market cap of $43.12 billion and its shares were traded at around $81.03. The company has a P/E ratio of 11.90 and P/S ratio of 2.69. The dividend yield of PNC Financial Services Group Inc. stocks is 2.17%; over the past 10 years, the company had an annual average earnings growth of 6.10%.
PNC Financial Services Group Inc. announced their 2013 third quarter results with revenues of $4.134 billion and net income of $1.04 billion. The company had a 2012 total revenue of $16.6 billion, a 5% increase from the 2011 total revenue. The 2012 net income was $3 billion, a 2.3% decrease from the 2011 net income.
On Jan. 22, Executive Vice President Neil F Hall sold 98,133 shares at an average price of $83.79. The price of the stock has decreased by 3.29% since. On 01/22/2014, Senior Vice Chairman Joseph C Guyaux sold 129,000 shares at an average price of $84.10. The price of the stock has decreased by 3.65% since. On 10/23/2013, President/CEO William S Demchak sold 56,584 shares at an average price of $75.44. The price of the stock has increased by 7.42% since.
Gilead Sciences Inc. (GILD, Financial): SVP, CFO Robin L Washington sold 35,600 Shares
On 01/02/2014, SVP, CFO Robin L Washington sold 35,600 shares at an average price of $75.03. The price of the stock has increased by 7.45% since. Gilead Sciences Inc. has a market cap of $123.62 billion and its shares were traded at around $80.62. The company has a P/E ratio of 44.10 and P/S ratio of 12.64. Over the past 5 years, Gilead Sciences Inc had an annual average earnings growth of 14.80%.
Gilead Sciences Inc. announced their 2013 third quarter results with revenues of $2.78 billion and gross profit of $2.1 billion; the net income was $788.6 million. The 2012 total revenue for Gilead Sciences Inc was $9.7 billion, a 15.7% increase from the 2011 total revenue. The 2012 gross profit was $7.23 billion, a 15.5% increase from the 2011 gross profit.
On Jan. 21, EVP, Corp & Med Affairs Gregg H Alton sold 120,000 shares at an average price of $80. The price of the stock has increased by 0.78% since. On Jan. 14, EVP, R&D and CSO Norbert W Bischofberger sold 90,000 shares at an average price of $74.23. The price of the stock has increased by 8.61% since. On Jan. 2, Chairman and CEO John Martin sold 140,625 shares at an average price of $75.02. The price of the stock has increased by 7.46% since.
Â
